CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
24 hedge funds and large institutions have $14.8M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 1 closing their positions.
Holders
24
Holders Change
+3
Holders Change %
+14.29%
% of All Funds
0.42%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
3
Reduced
8
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
BL
1
BCWM LLC
Overland Park,
Kansas
|
$10.1M |
2 |
2
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$1.42M |
3 |
3
Jane Street
New York
|
$748K |
4 |
4
UBS Group
Zurich,
Switzerland
|
$48K |
5 |
5
Fifth Third Bancorp
Cincinnati,
Ohio
|
$46K |